Alejandro Gabriel Schijman
Overview
Explore the profile of Alejandro Gabriel Schijman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
458
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Juiz N, Estupinan E, Hernandez D, Garcilazo A, Chadi R, Morales Sanfurgo G, et al.
PLoS Negl Trop Dis
. 2019 Jan;
13(1):e0007033.
PMID: 30650073
Several studies have proposed different genetic markers of susceptibility to develop chronic Chagas cardiomyopathy (CCC). Many genes may be involved, each one making a small contribution. For this reason, an...
12.
Triquell M, Diaz-Lujan C, Romanini M, Ramirez J, Paglini-Oliva P, Schijman A, et al.
Am J Reprod Immunol
. 2018 Mar;
80(1):e12852.
PMID: 29577492
Problem: The innate immune response of the placenta may participate in the congenital transmission of Chagas disease through releasing reactive oxygen and nitrogen intermediates. Method Of Study: Placental explants were...
13.
Lozano I, de Pablos L, Longhi S, Zago M, Schijman A, Osuna A
Sci Rep
. 2017 Mar;
7:44451.
PMID: 28294160
The exovesicles (EVs) are involved in pathologic host-parasite immune associations and have been recently used as biomarkers for diagnosis of infectious diseases. The release of EVs by Trypanosoma cruzi, the...
14.
Martinez M, Kowalewski M, Salomon O, Schijman A
Int J Parasitol Parasites Wildl
. 2016 Sep;
5(2):198-206.
PMID: 27617205
The transmission of Trypanosoma cruzi by vectors is confined to the Americas, and the infection circulates in at least two broadly defined transmission cycles occurring in domestic and sylvatic habitats....
15.
de Pablos L, Lozano I, Jercic M, Quinzada M, Gimenez M, Calabuig E, et al.
Sci Rep
. 2016 Jun;
6:27293.
PMID: 27270330
Trypanosoma cruzi is the etiological agent of Chagas disease, a neglected and emerging tropical disease, endemic to South America and present in non-endemic regions due to human migration. The MASP...
16.
Fernandez M, Marson M, Ramirez J, Mastrantonio G, Schijman A, Altcheh J, et al.
Mem Inst Oswaldo Cruz
. 2016 Mar;
111(3):218-21.
PMID: 26982179
Pharmacological treatment of Chagas disease with benznidazole (BNZ) is effective in children in all stages, but it is controversial in chronically infected adults. We report the pharmacokinetics and pharmacodynamics in...
17.
Miranda C, Solana M, Curto M, Lammel E, Schijman A, Alba Soto C
Acta Trop
. 2015 Aug;
152:8-16.
PMID: 26272680
Chagas disease is a major unsolved health issue in Latin America and an emerging threat worldwide. New drugs are urgently needed for chemotherapy as those available (benznidazole and nifurtimox) have...
18.
Pilar Fernandez M, Cecere M, Lanati L, Lauricella M, Schijman A, Gurtler R, et al.
Acta Trop
. 2014 Aug;
140:10-8.
PMID: 25090650
We assessed the diversity and distribution of Trypanosoma cruzi discrete typing units (DTU) in Triatoma infestans populations and its association with local vector-borne transmission levels at various geographic scales. At...
19.
Burgos J, Diez M, Vigliano C, Bisio M, Risso M, Duffy T, et al.
Clin Infect Dis
. 2010 Jul;
51(5):485-95.
PMID: 20645859
Background: One hundred years after the discovery of Chagas disease, it remains a major neglected tropical disease. Chronic Chagas heart disease (cChHD) is the most severe manifestation. Heart transplantation is...
20.
Duffy T, Bisio M, Altcheh J, Burgos J, Diez M, Levin M, et al.
PLoS Negl Trop Dis
. 2009 Apr;
3(4):e419.
PMID: 19381287
Background: This report describes a real-time PCR (Q-PCR) strategy to quantify Trypanosoma cruzi (T. cruzi) DNA in peripheral blood samples from Chagas disease patients targeted to conserved motifs within the...